S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q3 2024

RA Capital Management

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$8.67B
Total portfolio value
Positions
81
Reported securities
Top Holding
ASND
16.7% $1.45B
QoQ Changes
+8 / -6
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$1.45B16.72%$149.31$274.50+83.8%
16.7%
PCVXVAXCYTE INC$992.9M11.45%$114.27$58.39-48.9%
11.4%
JANXJANUX THERAPEUTICS INC$416.4M4.80%$45.43$15.54-65.8%
4.8%
LEGNLEGEND BIOTECH CORP-ADR$365.8M4.22%$48.73$29.91-38.6%
4.2%
RYTMRHYTHM PHARMACEUTICALS INC$318.8M3.68%$52.39$114.17+117.9%
3.7%
RNAMAVIDITY BIOSCIENCES INC$289.4M3.34%β€”β€”
3.3%
TYRATYRA BIOSCIENCES INC$244.9M2.82%$23.51$30.62+30.2%
2.8%
EVHEVOLENT HEALTH INC - A$240.8M2.78%$28.28$5.71-79.8%
2.8%
EWTXEDGEWISE THERAPEUTICS INC$237.8M2.74%$26.69$39.56+48.2%
2.7%
BIIBBIOGEN INC$229.6M2.65%$193.84$216.12+11.5%
2.6%
DYNDYNE THERAPEUTICS INC$229.2M2.64%$35.92$23.07-35.8%
2.6%
RXSTRXSIGHT INC$193.6M2.23%$49.43$5.61-88.7%
2.2%
BCAXBICARA THERAPEUTICS INC$177.2M2.04%$25.47$29.00+13.9%
2.0%
CLYMCLIMB BIO INC$159.9M1.84%$5.09$12.90+153.4%
1.8%
SPRYARS PHARMACEUTICALS INC$157.5M1.82%$14.50$8.56-41.0%
1.8%
ACLXARCELLX INC$154.6M1.78%$83.51β€”
1.8%
ARTVARTIVA BIOTHERAPEUTICS INC$152.2M1.76%$15.45$9.61-37.8%
1.8%
WVEWAVE LIFE SCIENCES LTD$149.3M1.72%$8.20$6.26-23.7%
1.7%
GERNGERON CORP$146.6M1.69%$4.54$1.36-70.0%
1.7%
VRNAVERONA PHARMA PLC - ADR$144.1M1.66%β€”β€”
1.7%
NAMSNEWAMSTERDAM PHARMA CO NV$133.9M1.54%$16.60$34.83+109.8%
1.5%
APGEAPOGEE THERAPEUTICS INC$115.2M1.33%$58.74$132.91+126.3%
1.3%
DAWNDAY ONE BIOPHARMACEUTICALS I$109.7M1.26%β€”β€”
1.3%
ETNB89BIO INC$104.9M1.21%β€”β€”
1.2%
RXRXRECURSION PHARMACEUTICALS-A$101.4M1.17%$6.59$3.80-42.3%
1.2%
LENZLENZ THERAPEUTICS INC$99.2M1.14%$23.74$5.89-75.2%
1.1%
PEPGPEPGEN INC$91.4M1.05%$8.55$1.76-79.4%
1.1%
AXSMAXSOME THERAPEUTICS INC$89.9M1.04%$89.87$244.31+171.8%
1.0%
GPCRSTRUCTURE THERAPEUTICS INC$83.3M0.96%$43.89$53.45+21.8%
1.0%
TRMLTOURMALINE BIO INC$65.3M0.75%β€”β€”
0.8%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (8)

TickerIssuerNotionalSince Filing
BCAXBICARA THERAPEUTICS INC$177.2M+13.9%
ARTVARTIVA BIOTHERAPEUTICS INC$152.2M-37.8%
BIOABIOAGE LABS INC$46.0M
IDYAIDEAYA BIOSCIENCES INC$42.7M
MBXMBX BIOSCIENCES INC$39.3M
XNCRXENCOR INC$11.6M
AVTXAVALO THERAPEUTICS INC$9.2M
CDTXCIDARA THEREAPEUTICS INC$7.6M

Exited Positions (6)

TickerIssuerNotional
LBPHLONGBOARD PHARMACEUTICALS IN$88.9M
URGNUROGEN PHARMA LTD$51.7M
NRIXNURIX THERAPEUTICS INC$13.6M
CYBNXXXXCYBIN INC$11.9M
MGNXMACROGENICS INC$8.8M
UNCYUNICYCIVE THERAPEUTICS INC$1.3M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
NUVLNUVALENT INC-A$8.9M+47.2%
BIIBBIOGEN INC$1.9M+20.6%+11.5%
RNAMAVIDITY BIOSCIENCES INC$68.8M+16.7%
ACLXARCELLX INC$66.1M+15.4%
RXSTRXSIGHT INC$-28.7M+6.0%-88.7%
PCVXVAXCYTE INC$373.4M+5.9%-48.9%
DYNDYNE THERAPEUTICS INC$15.7M+5.5%-35.8%
GHRSGH RESEARCH PLC$-32.2M+1.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
RGLSREGULUS THERAPEUTICS INC$-9.9M-87.7%
ANTXAN2 THERAPEUTICS INC$-9.8M-64.0%
ELVNENLIVEN THERAPEUTICS INC$-22.5M-50.0%
PRAXPRAXIS PRECISION MEDICINES I$-7.3M-38.3%
THRDTHIRD HARMONIC BIO INC$-9.1M-37.0%
VRNAVERONA PHARMA PLC - ADR$33.8M-34.4%
GERNGERON CORP$-49.3M-30.1%-70.0%
LXEOLEXEO THERAPEUTICS INC$-5.8M-18.8%
← Back to Hedge Funds